Cargando…
Classification of “Near-patient” and “Point-of-Care” SARS-CoV-2 Nucleic Acid Amplification Test Systems and a first approach to evaluate their analytical independence of operator activities
BACKGROUND: European legislation defines as "near-patient testing" (NPT) what is popularly and in other legislations specified as "point-of-care testing” (POCT). Systems intended for NPT/POCT use must be characterized by independence from operator activities during the analytic proced...
Autores principales: | Buchta, Christoph, Zeichhardt, Heinz, Badrick, Tony, Coucke, Wim, Wojtalewicz, Nathalie, Griesmacher, Andrea, Aberle, Stephan W., Schellenberg, Ingo, Jacobs, Ellis, Nordin, Gunnar, Schweiger, Christian, Schwenoha, Karin, Luppa, Peter B., Gassner, Ulrich M., Wagner, Thomas, Kammel, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249340/ https://www.ncbi.nlm.nih.gov/pubmed/37302248 http://dx.doi.org/10.1016/j.jcv.2023.105521 |
Ejemplares similares
-
Ignoring SARS-CoV-2 testing performance during COVID-19
por: Buchta, Christoph, et al.
Publicado: (2023) -
Design of external quality assessment schemes and definition of the roles of their providers in future epidemics
por: Buchta, Christoph, et al.
Publicado: (2023) -
Results of the first German external quality assessment scheme for the detection of monkeypox virus DNA
por: Vierbaum, Laura, et al.
Publicado: (2023) -
Evaluation of INSTAND e.V.’s external quality assessment for C-reactive protein and procalcitonin
por: Wojtalewicz, Nathalie, et al.
Publicado: (2019) -
The importance of external quality assessment data in evaluating SARS-CoV-2 virus genome detection assays
por: Buchta, Christoph, et al.
Publicado: (2022)